Galcanezumab effect on “whole pain burden” and multidimensional outcomes in migraine patients with previous unsuccessful treatments: a real-world experience

BACKGROUND: Clinical trials have demonstrated galcanezumab as safe and effective in migraine prevention. However, real-life data are still lacking and overlook the impact of galcanezumab on those different migraine facets strongly contributing to migraine burden. Herein we report the clinical experi...

Descripción completa

Detalles Bibliográficos
Autores principales: Silvestro, Marcello, Tessitore, Alessandro, Orologio, Ilaria, De Micco, Rosa, Tartaglione, Lorenzo, Trojsi, Francesca, Tedeschi, Gioacchino, Russo, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195341/
https://www.ncbi.nlm.nih.gov/pubmed/35698070
http://dx.doi.org/10.1186/s10194-022-01436-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195341/
https://www.ncbi.nlm.nih.gov/pubmed/35698070
http://dx.doi.org/10.1186/s10194-022-01436-6

Ejemplares similares